Department of Pharmacology and Chemical Biology, Institute of Medical Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA; and.
FASEB J. 2019 May;33(5):6622-6631. doi: 10.1096/fj.201802351R. Epub 2019 Feb 22.
M1 muscarinic acetylcholine receptors are highly expressed in key areas that control cognition, such as the cortex and hippocampus, representing one potential therapeutic target for cognitive dysfunctions of Alzheimer's disease and schizophrenia. We have reported that M1 receptors facilitate cognition by promoting membrane insertion of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor AMPA receptor subunit 1 (GluA1) through phosphorylation at Ser845. However, the signaling pathway is still unclear. Here we showed that adenylyl cyclase inhibitor 2',5'-dideoxyadenosine and PKA inhibitor KT5720 inhibited enhancement of phosphorylation of Ser845 and membrane insertion of GluA1 induced by M1 receptor activation. Furthermore, PI3K inhibitor LY294002 and protein kinase B (Akt) inhibitor IV blocked the effects of M1 receptors as well. Remarkably, the increase of the activity of PI3K-Akt signaling induced by M1 receptor activation could be abolished by cAMP-PKA inhibitors. Moreover, inhibiting the mammalian target of rapamycin (mTOR) complex 1, an important downstream effector of PI3K-Akt, by short-term application of rapamycin attenuated the effects of M1 receptors on GluA1. Furthermore, such effect was unrelated to possible protein synthesis promoted by mTOR. Taken together, these data demonstrate that M1 receptor activation induces membrane insertion of GluA1 a signaling linking cAMP-PKA and PI3K-Akt-mTOR pathways but is irrelevant to protein synthesis.-Zhao, L.-X., Ge, Y.-H., Li, J.-B., Xiong, C.-H., Law, P.-Y., Xu, J.-R., Qiu, Y., Chen, H.-Z. M1 muscarinic receptors regulate the phosphorylation of AMPA receptor subunit GluA1 a signaling pathway linking cAMP-PKA and PI3K-Akt.
M1 毒蕈碱型乙酰胆碱受体在控制认知的关键区域(如皮质和海马体)中高度表达,这代表了阿尔茨海默病和精神分裂症认知功能障碍的潜在治疗靶点之一。我们已经报道,M1 受体通过 Ser845 磷酸化促进 α-氨基-3-羟基-5-甲基-4-异恶唑丙酸受体 AMPA 受体亚基 1(GluA1)的膜插入,从而促进认知。然而,信号通路仍不清楚。在这里,我们表明,腺苷酸环化酶抑制剂 2',5'-二脱氧腺苷和蛋白激酶 A 抑制剂 KT5720 抑制了 M1 受体激活诱导的 Ser845 磷酸化和 GluA1 膜插入的增强。此外,PI3K 抑制剂 LY294002 和蛋白激酶 B(Akt)抑制剂 IV 也阻断了 M1 受体的作用。值得注意的是,M1 受体激活诱导的 PI3K-Akt 信号转导活性的增加可以被 cAMP-PKA 抑制剂所消除。此外,通过雷帕霉素(mTOR)短时间抑制哺乳动物雷帕霉素靶蛋白(mTOR)复合物 1,PI3K-Akt 的一个重要下游效应物,减弱了 M1 受体对 GluA1 的作用。此外,这种效应与 mTOR 可能促进的蛋白质合成无关。综上所述,这些数据表明,M1 受体激活诱导 GluA1 的膜插入,这是一个连接 cAMP-PKA 和 PI3K-Akt-mTOR 通路的信号通路,但与蛋白质合成无关。